Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
50 Innovative Drugs Approved for Launch in CN in 7M25, Surpassing 2024 Total Amt
Recommend 44 Positive 71 Negative 24 |
||||
|
||||
|
During the 14th Five-Year Plan period, China's National Medical Products Administration (NMPA) approved a total of 210 innovative drugs, maintaining a trend of accelerated growth, according to CCTV. In terms of both innovative drug pipelines and the number of clinical trial projects, China ranks among the highest in the world, with strong momentum in pharmaceutical innovation. Data shows that, in 7M25, the NMPA has approved 50 innovative drugs for launch, surpassing last year's 48. Among the 50 new drugs approved this year, there are several famous products that have garnered significant public attention, including China's first stem cell therapy drug and medications for rare diseases, providing new treatment options to address urgent clinical needs for patients. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
